rewirebio.iobenchmarks
Evidence claim

Relevance of ctdnalit-20261011-fragmentiawgs2026-protocol-test to "Which fragmentomics workflow detects tumour-derived plasma DNA under realistic low tumour fractions and fixed false-positive constraints?"

Use case
Select a plasma ctDNA fragmentomics detection workflow
Assessed by
Fragmentia-AI WGS paper: Independent test cohort by ichorCNA tumour fraction
Relevance
Direct evidence
Endpoint
AUC overall and within ichorCNA tumour-fraction strata, and sensitivity overall, by stratum and for low-TF cancers by stage at the training-derived 98%-specificity cutoff (observed specificity 0.97), on 5,996 independent samples

Measures the use case's endpoint for one workflow: detection within ichorCNA tumour-fraction strata, including below 3%, at a cutoff fixed in advance at 98% specificity in the training cohort and applied unchanged to an independent test cohort of 2,952 cancers and 3,044 non-cancer controls that was not used for fitting or model selection (observed specificity 0.97). Direct despite its limitations: the strata are ichorCNA estimates rather than measured tumour fractions, no comparator method is run on the cohort, the cohort is retrospective case-control, and the developer reports every value.

1 reviewed evaluation

Evidence

Source checking verifies the cited claim or transcription. It does not establish independent reproduction.

Evidence table

Inspect claims, sources and review details

Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.

One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.

40 evidence rows matching the loaded filters

Claims, original sources and review scope · Release 2026-11-21-c8bea25e5abb
Property and statementOriginal source and locationReview and provenance
Citation locations
2 values
  • source id
    ctdnalit-20261011-fragmentiawgs2026-source-article
    locator
    Results P8-P21; Methods P40-P60
  • source id
    ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1
    locator
    Table S4
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Citation locations
2 values
  • source id
    ctdnalit-20261011-fragmentiawgs2026-source-article
    locator
    Results P8-P21; Methods P40-P60
  • source id
    ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1
    locator
    Table S4
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.citation_locators

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison group
fragmentiawgs2026-tf-strata
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison group
fragmentiawgs2026-tf-strata
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_group

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison title
Fragmentia-AI WGS by ichorCNA tumour fraction (Molecular Biomedicine 2026)
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Comparison title
Fragmentia-AI WGS by ichorCNA tumour fraction (Molecular Biomedicine 2026)
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.comparison_title

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
3 values
  • Inspect every linked evaluation's source locator and preserved limitations before citing a result.
  • Tumour-fraction strata are ichorCNA estimates; do not read them as measured ctDNA fractions.
  • Do not combine with other protocols' results; cohorts, depth and thresholds differ.
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Constraints
3 values
  • Inspect every linked evaluation's source locator and preserved limitations before citing a result.
  • Tumour-fraction strata are ichorCNA estimates; do not read them as measured ctDNA fractions.
  • Do not combine with other protocols' results; cohorts, depth and thresholds differ.
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.constraints

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
AUC overall and within ichorCNA tumour-fraction strata, and sensitivity overall, by stratum and for low-TF cancers by stage at the training-derived 98%-specificity cutoff (observed specificity 0.97), on 5,996 independent samples
Context-only references
Generalizable cancer detection from ultra-low-pass WGS via deep contextual modeling of cfDNA sequences

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: Molecular Biomedicine, published online 2026-08-12; Europe PMC full-text JATS XML of PMC13469060
Retrieved: 2026-10-11T21:51:36Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: 8c2cd974ba60d7d29361adf31ee02bc705d7a5226b8423d47ecfdc32652b5ead

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

Endpoint
AUC overall and within ichorCNA tumour-fraction strata, and sensitivity overall, by stratum and for low-TF cancers by stage at the training-derived 98%-specificity cutoff (observed specificity 0.97), on 5,996 independent samples
Context-only references
Fragmentia-AI WGS paper, Supplementary Material 1 (Tables S1-S4, Figures S1-S9)

Original source ↗

ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4

Shared locator for this statement’s cited sources; not a separate locator for each citation.

Version: 43556_2026_538_MOESM1_ESM.docx, publisher supplementary file
Retrieved: 2026-10-11T21:52:25Z

not individually reviewed

No individual claim review recorded

Audit details

Field: attributes.endpoint

Source artifact SHA-256: df6f4b15b28075b1e45aa43ba426213bdc3ac2f6eda931937081e6e6055e85d0

Hash scope: Hash scope not separately documented; inspect source record

Inspected artifact

How to read the evidence

Sources and history

Release 2026-11-21-c8bea25e5abb · Record review: source checked

2 source records and release historyDownload this release (gzip)
Technical metadata and extraction receipts

Stable ID: use-case-mapping-ctdna-lit-20261011-fragmentiawgs2026-test

field
links:assessed_by:ctdnalit-20261011-fragmentiawgs2026-protocol-test
value
ctdnalit-20261011-fragmentiawgs2026-protocol-test
relevance
direct
endpoint
AUC overall and within ichorCNA tumour-fraction strata, and sensitivity overall, by stratum and for low-TF cancers by stage at the training-derived 98%-specificity cutoff (observed specificity 0.97), on 5,996 independent samples
rationale
Measures the use case's endpoint for one workflow: detection within ichorCNA tumour-fraction strata, including below 3%, at a cutoff fixed in advance at 98% specificity in the training cohort and applied unchanged to an independent test cohort of 2,952 cancers and 3,044 non-cancer controls that was not used for fitting or model selection (observed specificity 0.97). Direct despite its limitations: the strata are ichorCNA estimates rather than measured tumour fractions, no comparator method is run on the cohort, the cohort is retrospective case-control, and the developer reports every value.
constraints
Inspect every linked evaluation's source locator and preserved limitations before citing a result.; Tumour-fraction strata are ichorCNA estimates; do not read them as measured ctDNA fractions.; Do not combine with other protocols' results; cohorts, depth and thresholds differ.
limitations
Developer study: Geneseeq employees collected and sequenced the cohorts, developed the model and report every value.; Tumour-fraction strata are ichorCNA estimates, not measured fractions; the authors chose the 3% cutoff because the ichorCNA study reported 0.03 as its lower limit for detecting tumour from ULP-WGS (Results P8), so the low stratum holds cancers whose tumour fraction ichorCNA cannot resolve.; Retrospective case-control cohorts of clinically diagnosed cancers and non-cancer controls; not a screening population.; The cutoff is set at 98% specificity in the training cohort and applied unchanged; observed specificity in other cohorts differs (0.97 in the test cohort, 0.92 in the DELFI cohort).; No comparator method is evaluated on these cohorts; only Fragmentia-AI configurations are compared.; Sequenced at about 0.05x against about 0.1x for training.; The training cohort has 1,245 non-cancer controls, the same number as the ULP-WGS cohort of the Fragmentia-AI paper (Cell Reports Medicine 2026) from the same company, so the two studies may share samples; neither paper says.
citation locators
source id: ctdnalit-20261011-fragmentiawgs2026-source-article; locator: Results P8-P21; Methods P40-P60; source id: ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1; locator: Table S4
source locator
ctdnalit-20261011-fragmentiawgs2026-source-article: Results P8-P21; Methods P40-P60; ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1: Table S4
revision
1
reason
Add the tumour-fraction-stratified results of Fragmentia-AI WGS (Molecular Biomedicine 2026), retrieved 2026-10-11. Independently reviewed in docs/reviews/use-cases/plasma-ctdna-use-cases-2026-10-12.md.
comparison group
fragmentiawgs2026-tf-strata
comparison title
Fragmentia-AI WGS by ichorCNA tumour fraction (Molecular Biomedicine 2026)
headline metric
auroc
stratum label
Independent test cohort
stratum order
2
review
method: source-hash-verification; independent-cell-check; scope-review; reviewer: claude; reviewer note: Separate Claude review agent (reviewer-ctdna), independent of the extractor uc-ctdna; no human review claimed; date: 2026-10-12; note: Re-downloaded the pinned artifacts and matched their SHA-256; read Table S4 from the DOCX table XML with a separate reader written for this review (the extractor's script was not run) and checked each sensitivity against detected/total; compared the text values with Results P13, P14, P19 and P21.
reviewed evaluations
ctdnalit-20261011-fragmentiawgs2026-eval-test-high-medium-low-tf
pins
record id: ctdnalit-20261011-fragmentiawgs2026-eval-test-high-medium-low-tf; fields: status; links; attributes.origin; attributes.comparison; sha256: 9e97657665d30627e6ef4530fc5ab360cd09ce9c269c52cce106a731c022a959; record id: ctdnalit-20261011-fragmentiawgs2026-protocol-test; fields: status; name; description; facets; source_ids; links; attributes; sha256: 2179a30a1e318dbd805e97c54ac4dde76b3db2c02804f10d5dc272a0ce6d2400; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-auroc-high-tf; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 65137a9c43985d52c32642947ebd4bde0bc8d6a093ade209356d04ec9d723964; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-auroc-low-tf; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: cfac904a76543488e61c780ade8d6270018497aaf94ca7eb7151c3ec3e360b44; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-auroc-medium-tf; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: e8296c875352630cc4796d33134f073d797111292e5d3170769988780b295547; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-auroc-overall; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: bbb396b3afb8d9c0e2b3e4df2aee3f895bfde9ce57ebc19388214dab812ce160; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-sensitivity-cutoff; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 5be718704c1e4590138925a5d03767c86cdef71bc524aaac45816c45b55f8274; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-sensitivity-cutoff-high-tf; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 215092bfeaeb2201362ed675d8988e522adc41018dc77ed5802acd8233580d1f; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-sensitivity-cutoff-low-tf; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 2f94122210c433f2542f71385493e4ec79c5660db5b7034a0a18a3ed7dca244f; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-sensitivity-cutoff-low-tf-stage-i-ii; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 3ebaef591d6b72110ceb738b5edd78018aa36897f4eed46ce3efabcdb755b977; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-sensitivity-cutoff-low-tf-stage-iii-iv; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: fe9e7492ea3131b964adbf2241923beca8ad1e61925bb089d10e0a623aa2eb1b; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-sensitivity-cutoff-medium-tf; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: 36d4979830d0d1f08aa6f72ef1a4853d08640cbf452d1ac449e4cf865a351c74; record id: ctdnalit-20261011-fragmentiawgs2026-result-test-high-medium-low-tf-specificity-cutoff; fields: status; attributes.metric; attributes.metric_qualifier; attributes.printed_value; attributes.numeric_value; sha256: a4e94b1a2ba4ed2e54b14643d70cda848b90b166dd78bd49425d623fccc73475; record id: ctdnalit-20261011-fragmentiawgs2026-source-article; fields: status; attributes.artifact_sha256; sha256: c85207569268327bf692a01933c1db48952db3dbf3f66773c05fa2ee2fdfa4af; record id: ctdnalit-20261011-fragmentiawgs2026-source-supplementary-material-1; fields: status; attributes.artifact_sha256; sha256: 526f24376cdd6ae19db68d4b144f15032588f79a52e102dcdffd45bbf36f8b05; record id: use-case-plasma-ctdna-fragmentomics; fields: status; name; description; facets; attributes.question; attributes.decision; attributes.inputs; attributes.output; attributes.exclusions; attributes.setting; attributes.clinical_scope; attributes.intended_users; sha256: 01d27c2ce64a391055bddc6dec9d5db208df9bee3d5e679045dd3f4f04a0ca08
Related records

Suggest a correction